TuHURA Biosciences Company Insiders
HURA Stock | 4.49 0.38 9.25% |
Analysis of TuHURA Biosciences' management performance can provide insight into the company performance.
TuHURA |
Symbol | HURA |
Name | TuHURA Biosciences |
Type | Stock |
Country | United States |
Exchange | NASDAQ |
Information on TuHURA Biosciences Leadership is currently not available.
If you believe this information is not accurate please let us know and we will check it out. Check all delisted instruments across multiple markets.Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
BTC | Bitcoin | |
TRX | TRON | |
BNB | Binance Coin | |
ADA | Cardano | |
XRP | XRP |
Thematic Opportunities
Explore Investment Opportunities
TuHURA Biosciences' latest congressional trading
Congressional trading in companies like TuHURA Biosciences, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in TuHURA Biosciences by those in governmental positions are based on the same information available to the general public.
2024-11-22 | Representative Laurel Lee | Acquired $100K to $250K | Verify | ||
2024-11-21 | Representative Laurel Lee | Acquired $100K to $250K | Verify |
TuHURA Biosciences Management Team Effectiveness
The current year's Return On Equity is expected to grow to 17.77, whereas Return On Tangible Assets are projected to grow to (7.34). At present, TuHURA Biosciences' Other Current Assets are projected to decrease significantly based on the last few years of reporting. The current year's Total Current Assets is expected to grow to about 7.3 M, whereas Total Assets are forecasted to decline to about 3.7 M. TuHURA Biosciences' management efficiency ratios could be used to measure how well TuHURA Biosciences manages its routine affairs as well as how well it operates its assets and liabilities.The current year's Common Stock Shares Outstanding is expected to grow to about 82.1 M
TuHURA Biosciences Workforce Comparison
TuHURA Biosciences is currently under evaluation in number of employees category among its peers. The total workforce of Biotechnology industry is currently estimated at about 198,700. TuHURA Biosciences adds roughly 0.0 in number of employees claiming only tiny portion of stocks in Biotechnology industry.
TuHURA Biosciences Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific TuHURA Biosciences insiders, such as employees or executives, is commonly permitted as long as it does not rely on TuHURA Biosciences' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, TuHURA Biosciences insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Dearborn Dan over a month ago Acquisition by Dearborn Dan of 489848 shares of TuHURA Biosciences at 4.94 subject to Rule 16b-3 |
About TuHURA Biosciences Management Performance
The success or failure of an entity such as TuHURA Biosciences often depends on how effective the management is. TuHURA Biosciences management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of TuHURA management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the TuHURA management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (7.73) | (7.34) | |
Return On Capital Employed | (44.72) | (42.48) | |
Return On Assets | (7.73) | (7.34) | |
Return On Equity | 16.93 | 17.77 |
Please note, the presentation of TuHURA Biosciences' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, TuHURA Biosciences' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of TuHURA Biosciences' management manipulating its earnings.
Complementary Tools for TuHURA Stock analysis
When running TuHURA Biosciences' price analysis, check to measure TuHURA Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TuHURA Biosciences is operating at the current time. Most of TuHURA Biosciences' value examination focuses on studying past and present price action to predict the probability of TuHURA Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TuHURA Biosciences' price. Additionally, you may evaluate how the addition of TuHURA Biosciences to your portfolios can decrease your overall portfolio volatility.
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |